Health Trials

Immunotherapy Related Pruritus

1

Review clinical trials related to Immunotherapy Related Pruritus. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus

This is a phase 2, randomized, open-label, single-center study that will assess the efficacy of TriCalm Hydrogel®, a topical gel containing strontium, for treating pruritus related to immune checkpoint inhibitors (ICIs).

Participants needed: 28
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of California, San DiegoUpdated: Jun 30, 2026Locations: 1
Eligibility criteria

Patients aged 18 years or older. [+3]

Diagnosis of primary skin disorders with pruritus symptoms (e.g., atopic dermati... [+3]

Read more